{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:02Z","timestamp":1791920042340,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,18]],"date-time":"2016-08-18T00:00:00Z","timestamp":1471478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"CNPq (Brazilian National Council for Scientific and Technological Development)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00436-016-5227-7","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T20:10:49Z","timestamp":1471464649000},"page":"4397-4403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Trypanocidal and cysteine protease inhibitory activity of isopentyl caffeate is not linked in Trypanosoma brucei"],"prefix":"10.1007","volume":"115","author":[{"given":"Dietmar","family":"Steverding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1vio Rog\u00e9rio","family":"da N\u00f3brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Rushworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dami\u00e3o Pergentino","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,18]]},"reference":[{"key":"5227_CR1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s12033-010-9251-z","volume":"45","author":"WF An","year":"2010","unstructured":"An WF, Tolliday N (2010) Cell-based assays for high-throughput screening. Mol Biotechnol 45:180\u2013186","journal-title":"Mol Biotechnol"},{"key":"5227_CR2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/j.1460-2075.1985.tb03772.x","volume":"4","author":"T Baltz","year":"1985","unstructured":"Baltz T, Baltz D, Giroud C, Crockett J (1985) Cultivation in a semi-defined medium of animal infective forms of Trypanosoma brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense. EMBO J 4:1273\u20131277","journal-title":"EMBO J"},{"key":"5227_CR3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0885-4505(87)90046-6","volume":"37","author":"RB Brandt","year":"1987","unstructured":"Brandt RB, Laux JE, Yates SW (1987) Calculation of inhibitor K i and inhibitor type from the concentration of inhibitor for 50\u00a0% inhibition for Michaelis-Menton enzymes. Biochem Med Metab Biol 37:344\u2013349","journal-title":"Biochem Med Metab Biol"},{"key":"5227_CR4","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1021\/jm00021a006","volume":"38","author":"TR Burke Jr","year":"1995","unstructured":"Burke TR Jr, Fesen MR, Mazumder A, Wang J, Carothers AM, Grunberger D, Driscoll J, Kohn K, Pommier Y (1995) Hydroxylated aromatic inhibitors of HIV-1 integrase. J Med Chem 38:4171\u20134178","journal-title":"J Med Chem"},{"key":"5227_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1389450003349290","volume":"1","author":"CR Caffrey","year":"2000","unstructured":"Caffrey CR, Scory S, Steverding D (2000) Cysteine proteinases of trypanosome parasites: novel targets for chemotherapy. Curr Drug Targets 1:155\u2013162","journal-title":"Curr Drug Targets"},{"key":"5227_CR6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/270347a0","volume":"270","author":"SJ Collins","year":"1977","unstructured":"Collins SJ, Gallo RC, Gallagher RE (1977) Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature 270:347\u2013349","journal-title":"Nature"},{"key":"5227_CR7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","volume":"10","author":"V Delespaux","year":"2007","unstructured":"Delespaux V, de Koning HP (2007) Drugs and drug resistance in African trypanosomiasis. Drug Resist Updat 10:30\u201350","journal-title":"Drug Resist Updat"},{"key":"5227_CR8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.pt.2003.09.002","volume":"19","author":"AH Fairlamb","year":"2003","unstructured":"Fairlamb AH (2003) Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol 19:488\u2013494","journal-title":"Trends Parasitol"},{"key":"5227_CR9","first-page":"398","volume":"59","author":"DJ Grab","year":"1992","unstructured":"Grab DJ, Wells CW, Shaw MK, Webster P, Russo DC (1992) Endocytosed transferrin in African trypanosomes is delivered to lysosomes and may not be recycled. Eur J Cell Biol 59:398\u2013404","journal-title":"Eur J Cell Biol"},{"key":"5227_CR10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1017\/S0031182000000822","volume":"80","author":"H Hirumi","year":"1980","unstructured":"Hirumi H, Hirumi K, Doyle JJ, Cross GAM (1980) In vitro cloning of animal-infective bloodstream forms of Trypanosoma brucei. Parasitology 80:371\u2013382","journal-title":"Parasitology"},{"key":"5227_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0001-706X(93)90083-N","volume":"55","author":"W Huber","year":"1993","unstructured":"Huber W, Koella JC (1993) A comparison of three methods of estimating EC50 in studies of drug resistance of malaria parasites. Acta Trop 55:257\u2013261","journal-title":"Acta Trop"},{"key":"5227_CR12","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1021\/cr0101656","volume":"102","author":"F Lecaille","year":"2002","unstructured":"Lecaille F, Kaleta J, Br\u00f6mme D (2002) Human and parasitic papain-like cysteine proteases: their role in physiology and pathology and recent developments in inhibitor design. Chem Rev 102:4459\u20134488","journal-title":"Chem Rev"},{"key":"5227_CR13","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1286-4579(01)01432-0","volume":"3","author":"E Matovu","year":"2001","unstructured":"Matovu E, Seebeck T, Enyaru JC, Kaminsky R (2001) Drug resistance in Trypanosoma brucei ssp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes Infect 3:763\u2013770","journal-title":"Microbes Infect"},{"key":"5227_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1055\/s-2001-17351","volume":"67","author":"K Merschjohann","year":"2001","unstructured":"Merschjohann K, Sporer F, Steverding D, Wink M (2001) In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense. Planta Med 67:623\u2013627","journal-title":"Planta Med"},{"key":"5227_CR15","first-page":"1171","volume-title":"Manson\u2019s tropical diseases","author":"DH Molyneux","year":"1996","unstructured":"Molyneux DH, Pentreath V, Doua F (1996) African trypanosomiasis in man. In: Cook GC (ed) Manson\u2019s tropical diseases, 20th edn. Saunders, London, pp 1171\u20131196","edition":"20"},{"key":"5227_CR16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jama.1967.03120080053007","volume":"199","author":"GE Moore","year":"1967","unstructured":"Moore GE, Gerner RE, Franklin HA (1967) Culture of normal human leukocytes. J Am Med Assoc 199:519\u2013524","journal-title":"J Am Med Assoc"},{"key":"5227_CR17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0924-8579(03)00096-7","volume":"22","author":"NJ Nkemgu","year":"2003","unstructured":"Nkemgu NJ, Grande R, Hansell E, McKerrow JH, Caffrey CR, Steverding D (2003) Improved trypanocidal activities of cathepsin L inhibitors. Int J Antimicrob Agents 22:155\u2013159","journal-title":"Int J Antimicrob Agents"},{"key":"5227_CR18","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nrd2144","volume":"5","author":"S Nwaka","year":"2006","unstructured":"Nwaka S, Hudson A (2006) Innovative lead discovery strategies for tropical diseases. Nat Rev Drug Discov 5:941\u2013955","journal-title":"Nat Rev Drug Discov"},{"key":"5227_CR19","first-page":"1161","volume":"5","author":"IV Ogungbe","year":"2010","unstructured":"Ogungbe IV, Crouch RA, Haber WA, Setzer WN (2010) Phytochemical investigation of Verbesina turbacensis Kunth: trypanosome cysteine protease inhibition by (-)-bornyl esters. Nat Prod Commun 5:1161\u20131166","journal-title":"Nat Prod Commun"},{"key":"5227_CR20","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s11418-011-0613-z","volume":"66","author":"K Otoguro","year":"2012","unstructured":"Otoguro K, Iwatsuki M, Ishiyama A, Namatame M, Nishihara-Tsukashima A, Kiyohara H, Hashimoto T, Asakawa Y, Omura S, Yamada H (2012) In vitro antitrypanosomal activity of some phenolic compounds from propolis and lactones from Fijian Kawa (Piper methysticum). J Nat Med 66:558\u2013561","journal-title":"J Nat Med"},{"key":"5227_CR21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/cr950025u","volume":"97","author":"HH Otto","year":"1997","unstructured":"Otto HH, Schirmeister T (1997) Cysteine proteases and their inhibitors. Chem Rev 97:133\u2013172","journal-title":"Chem Rev"},{"key":"5227_CR22","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/j.bmc.2013.08.057","volume":"21","author":"JT Sanderson","year":"2013","unstructured":"Sanderson JT, Clabault H, Patton C, Lassalle-Claux G, Jean-Fran\u00e7ois J, Par\u00e9 AF, H\u00e9bert MJG, Surette ME, Touaibia M (2013) Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells. Bioorg Med Chem 21:7182\u20137193","journal-title":"Bioorg Med Chem"},{"key":"5227_CR23","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/expr.1998.4381","volume":"91","author":"S Scory","year":"1999","unstructured":"Scory S, Caffrey CR, Stierhof YD, Ruppel A, Steverding D (1999) Trypanosoma brucei: killing of bloodstream forms in vitro and in vivo by the cysteine proteinase inhibitor Z-Phe-Ala-CHN2. Exp Parasitol 91:327\u2013333","journal-title":"Exp Parasitol"},{"key":"5227_CR24","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1083\/jcb.131.5.1173","volume":"131","author":"D Steverding","year":"1995","unstructured":"Steverding D, Stierhof YD, Fuchs H, Tauber R, Overath P (1995) Transferrin-binding protein complex is the receptor for transferrin uptake in Trypanosoma brucei. J Cell Biol 131:1173\u20131182","journal-title":"J Cell Biol"},{"key":"5227_CR25","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2174\/138955706778195207","volume":"6","author":"D Steverding","year":"2006","unstructured":"Steverding D, Caffrey CR, Said M (2006) Cysteine proteinase inhibitors as therapy for parasitic diseases: advances in inhibitor design. Mini Rev Med Chem 6:1025\u20131032","journal-title":"Mini Rev Med Chem"},{"key":"5227_CR26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ijpara.2012.03.009","volume":"42","author":"D Steverding","year":"2012","unstructured":"Steverding D, Sexton DW, Wang X, Gehrke SS, Wagner GK, Caffrey CR (2012a) Trypanosoma brucei: chemical evidence that cathepsin L is essential for survival and a relevant drug target. Int J Parasitol 42:481\u2013488","journal-title":"Int J Parasitol"},{"key":"5227_CR27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.molbiopara.2012.06.007","volume":"185","author":"D Steverding","year":"2012","unstructured":"Steverding D, Sexton DW, Chrysochoidi N, Cao F (2012b) Trypanosoma brucei transferrin receptor can bind C-lobe and N-lobe fragments of transferrin. Mol Biochem Parasitol 185:99\u2013105","journal-title":"Mol Biochem Parasitol"},{"key":"5227_CR28","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1006\/expr.1998.4386","volume":"91","author":"L Troeberg","year":"1999","unstructured":"Troeberg L, Morty RE, Pike RN, Lonsdale-Eccles JD, Palmer JT, McKerrow JH, Coetzer TH (1999) Cysteine proteinase inhibitors kill cultured bloodstream forms of Trypanosoma brucei brucei. Exp Parasitol 91:349\u2013355","journal-title":"Exp Parasitol"},{"key":"5227_CR29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tetasy.2004.11.037","volume":"16","author":"C Vafiadi","year":"2005","unstructured":"Vafiadi C, Topakas E, Wong KKY, Suckling ID, Christakopoulos P (2005) Mapping the hydrolytic and synthetic selectivity of a type C feruloyl esterase (StFaeC) from Sporotrichum thermophile using alkyl ferulates. Tetrahedron Asymmetry 16:373\u2013379","journal-title":"Tetrahedron Asymmetry"},{"key":"5227_CR30","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.bmcl.2006.02.026","volume":"16","author":"R Vicik","year":"2006","unstructured":"Vicik R, Hoerr V, Glaser M, Schultheis M, Hansell E, McKerrow JH, Holzgrabe U, Caffrey CR, Ponte-Sucre A, Moll H, Stich A, Schirmeister T (2006) Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents. Bioorg Med Chem Lett 16:2753\u20132757","journal-title":"Bioorg Med Chem Lett"},{"key":"5227_CR31","volume-title":"Control of human African trypanosomiasis: a strategy for the African region. AFRO (AFR\/RC55\/11)","author":"World Health Organization","year":"2005","unstructured":"World Health Organization (2005) Control of human African trypanosomiasis: a strategy for the African region. AFRO (AFR\/RC55\/11), http:\/\/www.who.int\/trypanosomiasis_african\/resources\/afro_tryps_strategy.pdf . Accessed 10 Jun 2016"},{"key":"5227_CR32","unstructured":"World Health Organization (2016) African trypanosomiasis (sleeping sickness). World Health Org Fact Sheet 259, http:\/\/www.who.int\/mediacentre\/factsheets\/fs259\/en\/ . Accessed 10 Jun 2016"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-016-5227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-016-5227-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-016-5227-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T13:15:18Z","timestamp":1568294118000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-016-5227-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,18]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["5227"],"URL":"https:\/\/doi.org\/10.1007\/s00436-016-5227-7","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,18]]}}}